Evidence map›Paper›PMID 40589148›Full record

ArticleThe FEBS journal2025

Blood group O expression in normal tissues and tumors.

Ea Kristine Clarisse Tulin, Lukas Muerner, Tanya R McKitrick, Catherine A Tilton, Lauren E Pepi, Tianwei Jia, Maxence Noel, Leon Y Zheng, Sean R Stowell, Stephan von Gunten and 2 more

Abstract read
In one paragraph

Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Use of Microbial Microarrays to Define Antibody Specificity.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ea Kristine Clarisse TulinDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Lukas MuernerDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Tanya R McKitrickDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Catherine A TiltonDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Lauren E PepiDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Tianwei JiaDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Maxence NoelDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Leon Y ZhengJoint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sean R StowellJoint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Stephan von GuntenInstitute of Pharmacology, University of Bern, Inselspital, INO-F, Bern, Switzerland.
Jamie Heimburg-MolinaroDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Richard D CummingsDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-8918-5034

Funding

Project 2 - Convergence of innate immunity and microbial communities in the regulation of anti-blood group antibody developmentP01HL171803 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Sean R Stowell · 2024 to 2026
$10.0M
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)R24GM137763 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI RICHARD D CUMMINGS · 2020 to 2026
$5.8M
Smart Anti-Glycan Reagents to Generate the Human Glycome Atlas-SupplementU01CA199882 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CUMMINGS, RICHARD D, MERNAUGH, RAYMOND L · 2015 to 2017
$2.0M
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey SystemR01GM140201 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CUMMINGS, RICHARD D · 2021 to 2023
$1.5M
National Heart and Lung Institute PO1HL171803NCI NIH HHS U01 CA199882NCI NIH HHS U01CA199882NHLBI NIH HHS P01 HL171803NIGMS NIH HHS R01 GM140201NIGMS NIH HHS R01GM140210NIGMS NIH HHS R24 GM137763NIGMS NIH HHS R24GM137763Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_219605Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 320030_219451Swiss Cancer Research Foundation UniBE KFS-5936-08-2023-R
6 · The paper itself

Abstract

The H antigen (O blood group), the precursor to A and B blood groups, is expressed on human erythrocytes and other cells (e.g., endothelial cells). Remarkably, the specific expression of the H antigens is uncertain due to the lack of specific reagents for its detection. Here, we describe two monoclonal antibodies (mAbs), Tn4-31L and OmcFL3-02, generated by immunizing sea lampreys with human cells. Both mAbs are highly specific in comparison with the lectin Ulex europaeus agglutinin-I (UEA-I). We identified expression of H antigens in mammalian glycoproteins, human cells, and normal and malignant human tissues, discovering that different types of human carcinomas exhibit unexpected H antigen expression. Interestingly, H antigen detection in many cases was distinctly elevated by enzymatic desialylation, as well as being elevated in cells engineered to lack sialic acid. These highly specific mAbs will be valuable reagents in blood testing and for exploring the expression and function of H antigens.

Indexed as

ABO Blood-Group SystemAntibodies, MonoclonalPetromyzonAnimalsBlood Grouping and CrossmatchingCloning, MolecularHEK293 CellsHumansImmunohistochemistryK562 CellsNeoplasmsPolysaccharidesABO Blood-Group SystemAntibodies, MonoclonalPolysaccharidesfucoseglycan antibodiesglycobiologyH antigenlamprey antibodies

Identifiers

PMID40589148
PMCPMC12278781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.